Changes in the H/C ratio of cholesterof synthesized under different conditions
In two sets of experiments, ( a ) and (b), suspensions of hepatocytes containing glucose (1 1.1 mM), albumin (3.6%)), amino acids (East el al., 1973) and I3Hlwater (5OmCi) were incubated at 37'C in a volume of 15ml. The desmosterol H/C ratio was measured at the times indicated. To account for losses of hydrogen during experimental manipulations a factor of 22/18 was used to derive the cholesterol H/C ratio. All values are means & S.E.M. for the numbers of rats shown in parentheses. determine the H/C ratio (Table I) . Of the 22H atoms incorporated between acetyl-CoA and cholesterol, 7 arise directly from water and the remaining 15 from NADPH. If all the latter H atoms were labelled, then a maximum H/C ratio of 0.8 1 (i.e. 22/27) would result. It has been noted (Lakshmanan & Veech, 1977) that, in the presence of 13Hlwater, NADPH generated by the pentose phosphate pathway is unlabelled. unlike that formed from the malic enzyme pathway and from other sources. In the present work the H/C ratio after 2 h was 0.59 f 0.02 (Table la) . This value is significantly lower than the theoretical maximum and suggests that a substantial proportion of the NADPH used for sterol synthesis via the pentose phosphate pathway. Table 1 (a) also shows that in the absence of acetate and oleate, compared with that at 2 h. the H/C ratio was significantly higher at 3 h (paired t test, P <0.02) and at 4 h (P<O.OOl). This is probably due to a greater proportion of the sterol synthesized early in the incubation being derived from unlabelled isoprenoid precursors and/or to a change in the source of NADPH. Table I(a) also shows that acetate (6 mM) significantly decreases the H/C ratio by 12% at 2 h (paired t test, P <0.02), and Table 1 (b) shows that oleate ( 2 m~) increases the ratio by 25-30%. Paired t tests showed that the increase with oleate was significant at each of the three 1 h intervals (P <0.05). These results can be explained if the acetyl-CoA generated from fatty acids is itself labelled, and would also explain the high value of 0.89 obtained for the H/C ratio in the presence of octanoate by Andersen & Dietschy (1 979). During P-oxidation of fatty acids 3H can be incorporated into the 3-hydroxyacyl-CoA, formed at the enoyl-CoA hydratase step, and the acetyl-CoA subsequently produced would be labelled. The action of the protein-synthesis inhibitor cycloheximide is central to theories of the control of steroidogenesis. Cycloheximide and puromycin were postulated to inhibit synthesis of a rapidly-turning-over protein regulating the rate of cholesterol side-chain cleavage in the adrenal (Farese, 1964; Garren et al., 1965) and corpus luteum (Hermier et a/., 1971) . However, puromycin binds the terminal oxidase of the cholesterol side-chain-cleavage enzyme (Arthur & Boyd, 1974) , and there have been conflicting reports about the effect of the RNAsynthesis inhibitor Actinomycin D on steroidogenesis. Also, no 'regulatory protein' has yet been isolated. In view of the small number of inhibitors upon which the theory of a regulatory protein is based, we tested the effect of several inhibitors of eukaryotic protein synthesis on steroidogenesis in rat corpus-luteum mitochondria.
Immature rats (three groups of 36) containing luteinized ovaries (Parlow, 1958) were used. Four rats from each group t Deceased. were injected intraperitoneally (Lp.) close to the corpora lutea with protein synthesis inhibitor in 0.2ml of 0.9% saline, at the following dosehat, based on the LD,, (Table 1) : mitomycin C, 0.33 mg; daunomycin, 1.Omg; mithramycin C, 0.20mg; cycloheximide, 10.0mg; antramycin, 0.80mg; emetine, 2.1 mg; fusidic acid, 48.0 mg.
Control animals were injected i.p. (0.2ml of 0.9%) saline). Rats were killed 20min after injection. Mitochondria were prepared and incubations/pregnenolone determinations carried out as described by Mason el al. (1978) . Mitochondria were preincubated for IOmin at 37OC (mitochondria1 protein concn. 1-1.5 mg/mI +exogenous cholesterol ( IOopM)]. Cholesterol sidechain-cleavage activity was assayed, after initiation of steroidogenesis with isocitrate (IOmM), by pregnenolone radioimmunoassay.
With the exception of cycloheximide, no inhibition of steroidogenesis was observed in mitochondria of rats injected with inhibitors of RNA/protein synthesis ( Table 2 ). The lack of short-term inhibition of RNA-synthesis inhibitors resembles that reported for actinomycin D. The effect of the protein-synthesis inhibitors fusidic acid and emetine, however, contrasts with the inhibition of steroidogenesis caused by cycloheximide. Emetine and fusidic acid act at two of the three sites at which cycloheximide supposedly inhibits protein synthesis (Table 1) VOl. I I BIOCHEMICAL SOCIETY TRANSACTIONS , 1969; Pestka, 1971) . The third site of cycloheximide inhibition (ribosome binding of formylmethionyl-tRN A), may be the process important in regulation of steroidogenesis. However, inhibition at later stages of protein synthesis caused by emetine/fusidic acid presumably also prevents earlier stages of protein synthesis by product inhibition.
A difficulty in interpreting experiments involving injected inhibitors lies in possible diffusion barriers between the injection site and the target cell. However, similarities in the structures of cycloheximide and emetine suggest that they exhibit similar diffusion characteristics (Oleiwick, 1977) . and fusidic acid diffuses rapidly within human tissues (Jensen & Quaade, 1964; Chadwick & Jackson, 1969) .
These experiments suggest that inhibitors of protein synthesis do not necessarily cause short-term inhibition of steroidogenesis. The effect of cycloheximide may be distinct from its inhibition of protein synthesis (Farese, 1982) .
We Correlations have been made, in numerous studies, between above-average concentrations of cholesterol in human plasma and the incidence of coronary heart disease. The methods used to measure cholesterol in such investigations are not specific, but it has been tacitly assumed that other sterols (which normally amount to no more than 0.2% of the total sterols) can be disregarded. We are concerned with the possible occurrence of sterols that could show biological activity even at low concentrations. Current work stems from our original discovery (Gray el al., 1971) of cholesterol a-epoxide in the serum of hypercholesterolaemic patients. In the present communication we outline methods of concurrent ('profile') analysis, based ultimately on g.1.c.-mass spectrometry, of a group of oxygenated sterols isolable from saponified extracts of plasma or serum. In view of recent emphasis (Miller, 1979) on the markedly different role of each of the three major lipoprotein fractions, high-density, low-density and very-low-density lipoproteins, in cardiovascular health and disease. we also describe the first measurements of concentrations of oxygenated sterols in each of three lipoprotein fractions from a human serum.
Lipoprotein fractions were isolated from 10-100ml of plasma or serum by ultracentrifugation (Have1 et al.. 1955) at 250000g
and at 2°C. Very-low-density lipoprotein (density range
